If you don't measure it, you can't improve it: Success and shortcomings of genomic assays in early breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

If you don't measure it, you can't improve it: Success and shortcomings of genomic assays in early breast cancer

Published:2020-06-10 Issue:17 Volume:126 Page:3922-3925
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Danciu Oana C.¹^ORCID,Chen Zhengjia²³^ORCID,Hoskins Kent F.¹^ORCID

Affiliation:

1. Division of Hematology and Oncology Department of Medicine University of Illinois at Chicago College of Medicine Chicago Illinois USA

2. Division of Epidemiology and Biostatistics School of Public Health University of Illinois at Chicago Chicago Illinois USA

3. Biostatistics Shared Resource Core University of Illinois Cancer Center Chicago Illinois USA

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32955

Reference20 articles.

1. Breast

2. Clinical Validity/Utility, Change in Practice Patterns, and Economic Implications of Risk Stratifiers to Predict Outcomes for Early-Stage Breast Cancer: A Systematic Review

3. 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

4. Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

5. Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP